Physician

Abraham Sanders, MD

According to 2025 Medicare claims, Abraham Sanders, MD (NPI: 1225125313) practices pulmonary disease in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is WEILL MEDICAL COLLEGE OF CORNELL (NPI: 1285742122; TIN: 131623978) and primary practice location at 10065-8722. Sanders is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Sanders' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,510 traditional Medicare patients, billed 4,076 HCPCS/CPT codes, and received $185,652 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,036 prescription claims across 306 beneficiaries totaling $861,145 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 603 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $243,089 to $185,652. In contrast, Part D prescription costs have moved sharply higher in recent years, from $289,369 to $861,145. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,525	5,754	$243,089
2016	1,543	5,605	$250,536
2017	1,701	5,643	$257,890
2018	1,781	5,741	$251,304
2019	1,757	5,629	$262,303
2020	741	1,745	$102,025
2021	1,152	2,823	$172,026
2022	1,255	3,064	$144,360
2023	1,380	3,448	$156,621
2024	1,510	4,076	$185,652

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	223	1,596	$289,369
2016	247	1,968	$392,971
2017	299	2,021	$353,492
2018	312	2,169	$415,183
2019	350	2,493	$521,665
2020	356	2,550	$699,916
2021	334	2,069	$784,477
2022	365	2,161	$1,033,153
2023	361	2,069	$1,019,251
2024	306	2,036	$861,145

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	35	651	$56,454
2016	63	646	$50,767
2017	69	686	$75,478
2018	70	766	$68,604
2019	80	749	$65,188
2020	53	430	$50,516
2021	47	455	$58,730
2022	67	533	$46,117
2023	51	532	$42,825
2024	67	603	$66,316

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	176	261	$117
94729	Test to examine how well the lungs exchange gases	1,093	1,230	$41
94060	Test to measure expiratory airflow and volume changes before and after medication administration	417	444	$27
94010	Test to measure expiratory airflow and volume	646	740	$23
94726	Test to determine lung volumes using sensors	165	170	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	176	10,500	$219,768
Prolastin C	Alpha-1-Proteinase Inhibitor	12	336	$115,219
Nucala	Mepolizumab	17	502	$62,532
Dupixent Syringe	Dupilumab	13	364	$48,647
Breo Ellipta	Fluticasone/Vilanterol	75	3,630	$46,172

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	26	$26,172
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	32	221	$15,828
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	13	$13,239
E1392	Portable oxygen concentrator, rental	Y	24	169	$6,219
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	15	$1,506

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Abraham Sanders, MD?

Tedicare shows public-source Medicare data for Abraham Sanders, MD (NPI 1225125313), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Sanders, MD have ACO affiliation data?

Abraham Sanders, MD is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Abraham Sanders, MD?

Abraham Sanders, MD is linked to WEILL MEDICAL COLLEGE OF CORNELL (billing NPI 1285742122) in the available physician profile data.

Does Abraham Sanders, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.